Shirya Rashid/LinkedIn
Aug 31, 2026, 14:21
Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
Shirya Rashid, Scientific Consultant in Toronto, Canada Area, shared a post on LinkedIn about a recent article by Bernardo F. Spiazzi et al. published in JAMA Cardiology, adding:
“Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients – A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial: in JAMA Cardiology”
Title: Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients
Authors: Bernardo F. Spiazzi, Danielle Brennan, Carolina P. Zingano

Stay updated on all scientific advances with Hemostasis Today.
Bempedoic Acid
Bernardo F. Spiazzi
Cardiology
Cardiovascular Disease
cardiovascular risk
Carolina P. Zingano
Cholesterol
CLEAR Outcomes
Clinical Medicine
clinical trials
Danielle Brennan
evidence-based medicine
Headlines
Hemostasis
Hemostasis News
Hemostasis Today
JAMA Cardiology
LDL Cholesterol
Lipid Lowering Therapy
medical education
Medical Research
preventive cardiology
Randomized Clinical Trial
Shirya Rashid
Statin intolerance
thrombosis
venous thromboembolism
VTE
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC